Scarica l'app Stockscreener
1.90
1.04%
-0.02
Dopo l'orario di chiusura:
1.91
0.01
+0.53%
Precedente Chiudi:
$1.92
Aprire:
$1.95
Volume 24 ore:
309.87K
Relative Volume:
1.16
Capitalizzazione di mercato:
$55.39M
Reddito:
-
Utile/perdita netta:
$-25.94M
Rapporto P/E:
-1.3768
EPS:
-1.38
Flusso di cassa netto:
$-15.79M
1 W Prestazione:
+13.10%
1M Prestazione:
+8.57%
6M Prestazione:
-9.09%
1 anno Prestazione:
-43.28%
Intervallo 1D:
$1.8201
$1.9998
Intervallo di 1 settimana:
$1.60
$2.03
Portata 52W:
$1.40
$4.24
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Nome
MAIA Biotechnology Inc
Settore
Industria
Telefono
312 416 8592
Indirizzo
444 West Lake Street, Suite 1700, Chicago
Confronta MAIA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.90 | 55.39M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
MAIA Biotechnology Inc Borsa (MAIA) Ultime notizie
MAIA Biotechnology partners with Roche for cancer treatment studies By Investing.com - Investing.com South Africa
Maia Biotechnology Signs Clinical Supply Deal With Roche; Shares Rise - MarketScreener
MAIA Biotech (MAIA) Partners with Roche for Cancer Treatment Study - GuruFocus
MAIA Biotechnology, Inc. Announces Master Clinical Supply Agreement with Roche for Hard-To-Treat Cancer Therapies - marketscreener.com
MAIA Biotechnology in pact with Roche for cancer treatments - Seeking Alpha
MAIA Biotechnology partners with Roche for cancer treatment studies - Investing.com
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies - BioSpace
MAIA Biotechnology Announces Agreement with Roche - TipRanks
MAIA Biotechnology Enters Inducement Offer Agreements - TipRanks
Short Interest in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Declines By 35.8% - Defense World
MAIA Biotechnology to Present at BIO International Convention 2025 - BioSpace
Jane Street Group LLC Makes New Investment in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) - Defense World
MAIA Biotechnology Reports Positive Phase 2 Trial Results - TipRanks
Why Is MAIA Biotechnology Stock Trading Higher On Thursday?MAIA Biotechnology (AMEX:MAIA) - Benzinga
MAIA Biotechnology's Promising Results in Lung Cancer Trial | MA - GuruFocus
MAIA Biotechnology's Promising Results in Lung Cancer Trial | MAIA Stock News - GuruFocus
MAIA Biotechnology Says New Responder In Non-Small Cell Lung Cancer Phase 2 Clinical Trial - marketscreener.com
MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial - Business Wire
MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer - BioSpace
MAIA Biotechnology Reports Promising Results from THIO-101 Phase 2 Trial | MAIA Stock News - GuruFocus
Maia Biotechnology Says Ateganosine Treatment Extends Median Overall Survival in Lung Cancer Study - marketscreener.com
Maia Biotechnology stock rises following positive trial results By Investing.com - Investing.com Nigeria
Maia Biotechnology stock rises following positive trial results - Investing.com Australia
MAIA Biotechnology Showcases Promising THIO-101 Trial Data - TipRanks
MAIA Biotechnology Announces Private Placement Agreement - TipRanks
MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 4.1% Higher – Still a Buy? - Defense World
MAIA Biotechnology secures $669,500 in private placement By Investing.com - Investing.com South Africa
MAIA Biotechnology Announces Private Placement of Approximately $669,500 - BioSpace
MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial - Yahoo
CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000 - BioSpace
MAIA Biotechnology secures $669,500 in private placement - Investing.com
MAIA Biotechnology doubles authorized shares - Investing.com Australia
MAIA Biotechnology doubles authorized shares By Investing.com - Investing.com South Africa
MAIA Biotechnology Increases Authorized Common Stock Shares - TipRanks
MAIA Biotechnology Approves Key Changes at Annual Meeting - TipRanks
MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting - Business Wire
MAIA Biotechnology Announces Director Participation in Recent Private Placement - Business Wire
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
MAIA Biotechnology Raises $1.08M in Private Placement - TipRanks
MAIA Biotechnology launches $1.08M private placement - MSN
CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement - Business Wire
MAIA Biotechnology secures $1.08 million in private placement By Investing.com - Investing.com Canada
Maia Biotechnology Announces $1.08 Million Private Placement - marketscreener.com
MAIA Biotechnology secures $1.08 million in private placement - Investing.com
MAIA Biotechnology Raises $1.08M at $1.50 Per Share to Advance Phase II Cancer Trial - Stock Titan
MAIA Biotechnology Inc Azioni (MAIA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
MAIA Biotechnology Inc Azioni (MAIA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Guerrero Ramiro | Director |
May 08 '25 |
Buy |
1.50 |
20,000 |
30,000 |
588,218 |
| Smith Stan | Director |
May 08 '25 |
Buy |
1.50 |
66,666 |
99,999 |
1,271,726 |
| Guerrero Ramiro | Director |
Mar 03 '25 |
Buy |
1.50 |
33,333 |
50,000 |
568,218 |
| Smith Stan | Director |
Mar 03 '25 |
Buy |
1.50 |
25,000 |
37,500 |
1,205,060 |
| Guerrero Ramiro | Director |
Feb 24 '25 |
Buy |
1.50 |
73,333 |
110,000 |
534,885 |
| Smith Stan | Director |
Feb 24 '25 |
Buy |
1.50 |
50,000 |
75,000 |
1,180,060 |
| Smith Stan | Director |
Dec 13 '24 |
Buy |
1.87 |
25,000 |
46,800 |
1,130,060 |
| Guerrero Ramiro | Director |
Dec 13 '24 |
Buy |
1.87 |
53,418 |
99,998 |
514,970 |
| Luput Cristian | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
389,483 |
| CHAOUKI STEVEN M | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
111,024 |
1.45%
0.86%
Capitalizzazione:
|
Volume (24 ore):